{"status":"ok","message-type":"event-list","message":{"next-cursor":"a47064b1-40fc-42ec-95d6-f981150fc2f1","total-results":9,"items-per-page":1000,"events":[{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1074\/jbc.273.36.23534","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2012-12-06T00:00:00Z","subj_id":"https:\/\/lens.org\/005-020-936-589-298","id":"01c24b20-2826-1271-1c2a-6900ca35e5a9","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Method For Modelling, Optimizing, Parameterizing, Testing And\/Or Validating A Dynamic Network Or Network Perturbations","pid":"https:\/\/lens.org\/005-020-936-589-298","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-11T10:58:18Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1074\/jbc.273.36.23534","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2014-12-02T00:00:00Z","subj_id":"https:\/\/lens.org\/056-182-612-322-425","id":"f20e67a7-d1f5-336e-b2b6-97afef2adde4","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Use Of Opioids Or Opioid Mimetics For The Treatment Of Resistant Cancer Patients","pid":"https:\/\/lens.org\/056-182-612-322-425","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-11T12:32:44Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1074\/jbc.273.36.23534","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2006-11-14T00:00:00Z","subj_id":"https:\/\/lens.org\/068-304-446-443-923","id":"f4073c68-7d48-1d09-d63b-1c56a465e826","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Screening Assay For Agents That Alter Target Of Rapamycin Activity","pid":"https:\/\/lens.org\/068-304-446-443-923","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-11T15:40:22Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1074\/jbc.273.36.23534","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2010-02-03T00:00:00Z","subj_id":"https:\/\/lens.org\/087-844-602-413-934","id":"e70e33bd-fcfa-1922-7132-b0cda77766b5","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Use Of Opioids Of The Methadone Group For The Treatment Of Resistant Cancer Patients","pid":"https:\/\/lens.org\/087-844-602-413-934","jurisdiction":"EP"},"source_id":"cambia-lens","timestamp":"2017-11-11T21:08:02Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1074\/jbc.273.36.23534","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2014-02-04T00:00:00Z","subj_id":"https:\/\/lens.org\/098-341-492-836-614","id":"1b5327b9-26d3-a083-af7d-94e0a95c36f0","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Screening Assay For Agents That Alter Target Of Rapamycin Activity","pid":"https:\/\/lens.org\/098-341-492-836-614","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-12T00:09:20Z","relation_type_id":"cites"},{"license":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","obj_id":"https:\/\/doi.org\/10.1074\/jbc.273.36.23534","source_token":"8676e950-8ac5-4074-8ac3-c0a18ada7e99","occurred_at":"2012-03-20T00:00:00Z","subj_id":"https:\/\/doi.org\/10.1002\/jcp.24004","id":"c52d73b8-0074-4cea-9ec3-f41be495bd3e","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","message_action":"create","source_id":"crossref","timestamp":"2019-06-21T05:18:36Z","relation_type_id":"references"},{"license":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","obj_id":"https:\/\/doi.org\/10.1074\/jbc.273.36.23534","source_token":"8676e950-8ac5-4074-8ac3-c0a18ada7e99","occurred_at":"2001-01-02T00:00:00Z","subj_id":"https:\/\/doi.org\/10.1073\/pnas.98.1.136","id":"5630a905-c25c-419e-af8f-dff4976389eb","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","message_action":"create","source_id":"crossref","timestamp":"2019-07-28T11:46:25Z","relation_type_id":"references"},{"license":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","obj_id":"https:\/\/doi.org\/10.1074\/jbc.273.36.23534","source_token":"8676e950-8ac5-4074-8ac3-c0a18ada7e99","occurred_at":"2012-03-27T00:00:00Z","subj_id":"https:\/\/doi.org\/10.1126\/scisignal.2002469","id":"819b34e3-2740-4611-a441-f1532a55fb02","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","message_action":"create","source_id":"crossref","timestamp":"2019-11-30T23:00:38Z","relation_type_id":"references"},{"license":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","obj_id":"https:\/\/doi.org\/10.1074\/jbc.273.36.23534","source_token":"8676e950-8ac5-4074-8ac3-c0a18ada7e99","occurred_at":"2018-08-03T00:00:00Z","subj_id":"https:\/\/doi.org\/10.1515\/chem-2018-0074","id":"a47064b1-40fc-42ec-95d6-f981150fc2f1","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","message_action":"create","source_id":"crossref","timestamp":"2019-12-26T13:17:06Z","relation_type_id":"references"}]}}